AI-formulated medicine to be tested on humans for the first time

Prescription Medication

It took less than a year to develop the drug, which is designed to treat OCD.

A drug designed entirely by artificial intelligence is about to enter clinical human trials for the first time. The drug, which is intended to treat obsessive-compulsive disorder, was discovered using AI systems from Oxford-based biotech company Exscientia. While it would usually take around four and a half years to get a drug to this stage of development, Exscientia says that by using the AI tools it’s taken less than 12 months.

Continue reading… “AI-formulated medicine to be tested on humans for the first time”

0